type here...

CATEGORIES

Press Release

LATEST

Editors Choice

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Medika Life -
Press Release

MITRE-Harris Poll Survey Finds Half of Patients in the US Feel Ignored or Doubted When Seeking Medical Treatment

Medika Life -
Digital Health

First “Global State of Digital Health Report” Tapping into 200 Million Data Points Examines More Than 12,000 Digital Health Ventures Now Available

Medika Life -
Press Release

Cumulus Neuroscience Appoints Digital Health and Pharma Executive Aman Bhatti, MD as Chief Executive Officer

Medika Life -
Anxiety and Depression

U.S. Prepares Launch of a National Three-Digit Number for the Mental Health Crisis Hotline

Medika Life -
Press Release

Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience

Medika Life -
Press Release

Largest Coordinated HIV Testing Event in the Nation on June 27th

Medika Life -
Press Release

Galien Foundation Announces New Prix Galien Award Category, “Incubators, Accelerators and Equity – Foundational Support for Health Innovation”

Medika Life -
For Doctors

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained

Medika Life -
Press Release

Cogitativo Joins the Veterans Health Administration to Address the Deferred Care Challenge Using AI-Enabled Solution

Medika Life -
123...12Page 2 of 12

TRENDING

EDITORS CHOICE

First Hospitals in U.S. Implant Next-gen Cardiac Device to Reduce Stroke Risk

Medika Life -
The WATCHMAN FLX is the only FDA-approved device for the reduction of stroke risk in patients with non-valvular atrial fibrillation (A Fib).

FDA Approves New Opioid, Olinvyk, for Intravenous Use in Hospitals

Medika Life -
the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults

MITRE-Harris Poll Survey Finds Half of Patients in the US Feel Ignored or Doubted When Seeking Medical Treatment

Medika Life -
A new survey finds 52 percent of individuals feel their symptoms are “ignored, dismissed, or not believed” when seeking medical treatment. That number rises to 6-in-10 within the Hispanic community.

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

Medika Life -
Collaboration supports the patient journey across the care continuum and eases transitions and care from the hospital to home

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories